Drugs / Ginkgo biloba extract EGb 761
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00251238 | Nov 2005 → Mar 2006 | Raynaud disease | VSM Geneesmiddelen b.v. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo biloba extract EGb 761 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00251238 ↗ |